Welcome to our dedicated page for Thermo Fishr Sci news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fishr Sci stock.
Thermo Fisher Scientific Inc. (TMO) is a global leader in life sciences, diagnostics, and laboratory innovation, providing essential tools for scientific research and healthcare advancements. This dedicated news hub offers investors and industry professionals timely updates on TMO's strategic initiatives, financial performance, and technological breakthroughs.
Access curated press releases and articles covering earnings reports, product launches, acquisitions, and partnerships. Our repository ensures you stay informed about developments in analytical technologies, diagnostic solutions, and biopharma services that shape the company's growth trajectory.
Discover updates across TMO's core operations: analytical instrumentation advancements, life science research tools, and specialty diagnostic innovations. Bookmark this page for streamlined access to verified information supporting informed analysis of Thermo Fisher's market position and industry impact.
Thermo Fisher Scientific (NYSE: TMO) reported first quarter 2023 results with revenue of $10.71 billion, a 9% decrease from $11.82 billion last year. However, core organic revenue grew by 6%. The company posted GAAP diluted EPS of $3.32, down from $5.61 in the previous year. Adjusted EPS also declined to $5.03 from $7.25. Despite the revenue drop, Thermo Fisher launched innovative products, strengthened customer partnerships, and secured agreements for 100% renewable energy by 2026, aiming for a 50% reduction in greenhouse gas emissions by 2030. The company repurchased $3.0 billion of stock and raised its dividend by 17%. The earnings call for further guidance is scheduled for April 26, 2023.
Thermo Fisher Scientific Inc. (NYSE: TMO) has announced its 2023 Investor Day, scheduled for May 24, 2023, at 9:00 a.m. ET in New York City. The event will feature presentations from the senior management team and will conclude with a question-and-answer session. Interested parties can access the live webcast via the Investors section of the Thermo Fisher website, with a replay available post-event.
Thermo Fisher is recognized as a leader in serving science, boasting over $40 billion in annual revenue. The company focuses on enabling advancements in life sciences, improving diagnostics, and developing innovative therapies through its renowned brands, including Thermo Scientific, Applied Biosystems, and Invitrogen. For more information, visit www.thermofisher.com.
Thermo Fisher Scientific Inc. (NYSE: TMO) will release its financial results for the first quarter of 2023 on April 26, 2023, before market opening. A conference call is scheduled for 8:30 a.m. EST on the same date to discuss financial performance and future expectations. The company reported annual revenue exceeding $40 billion, emphasizing its mission to enhance health and safety globally through advanced scientific services.
Investors can access the earnings release and listen to the call via the company’s website.
FAQ
What is the current stock price of Thermo Fishr Sci (TMO)?
What is the market cap of Thermo Fishr Sci (TMO)?
